| Authors: |
Vazquez R; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Deredec N; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Boussaid I; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Boncoeur P; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France., Knosp C; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Houvert A; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Zalmai L; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France., Friedrich C; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Almire C; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Dussiau C; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Willems L; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France., Birsen R; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France., Decroocq J; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France., Bouscary D; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France., Kosmider O; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Kordasti S; Comprehensive Cancer Centre, King's College, London, UK.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium., Fontenay M; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium., Simoni Y; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium., Chapuis N; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium. |
